Methods of regulating expression of genes or of gene products using substituted tetracycline compounds

Details for Australian Patent Application No. 2007249696 (hide)

Owner Paratek Pharmaceuticals, Inc.

Inventors Nelson, Mark L.; Draper, Michael

Agent Cullen & Co

Pub. Number AU-A-2007249696

PCT Pub. Number WO2007/133798

Priority 60/800,662 15.05.06 US

Filing date 15 May 2007

Wipo publication date 22 November 2007

International Classifications

A61K 31/00 (2006.01)

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/133798 Priority application(s): WO2007/133798

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007249698-Toll-like receptor (TLR) stimulation for ocular angiogenesis and macular de- generation

2007249695-Methods of regulating expression of genes or of gene products using substituted tetracycline compounds